Akers Biosciences, Inc., together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. The company's marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness. Its marketed products also include PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests for Heparin/PF4 antibodies to detect an allergy to the used blood thinner, Heparin; seraSTAT, a rapid blood cell separator; Tri-Cholesterol Check', a rapid test for total and high density lipoprotein cholesterol and estimates low density lipo protein; and BreathScan OxiCHek, a breath test for oxidative stress using the Lync reader and digital app. The company's pipeline products comprise Breath Diabetic Ketoacidosis, a disposable breath ketone device for diabetic monitoring; Breath PulmoHealth Check', a suite of breath tests for biomarkers indicating asthma, chronic obstructive pulmonary disease, and lung cancer; PIFA PLUSS Chlamydia, a rapid test for sexually transmitted diseases; and BreathScan KetoChek, a breath test for ketosis using the Lync reader and digital app. Akers Biosciences, Inc. was founded in 1989 and is headquartered in Thorofare, New Jersey.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AKER
Previous Symbol
CUSIPN/A
Phone856-848-8698
Debt
Debt-to-Equity RatioN/A
Current Ratio3.44
Quick Ratio3.09
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$3.93 million
Price / Sales3.68
Cash FlowN/A
Price / Cash FlowN/A
Book Value$1.05 per share
Price / Book1.10
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-7,360,000.00
Net Margins-346.69%
Return on Equity-107.79%
Return on Assets-85.96%
Miscellaneous
Employees32
Outstanding Shares12,470,000
Market Cap$14.47 million
OptionableNot Optionable
Akers Biosciences (NASDAQ:AKER) Frequently Asked Questions
What is Akers Biosciences' stock symbol?
Akers Biosciences trades on the NASDAQ under the ticker symbol "AKER."
How were Akers Biosciences' earnings last quarter?
Akers Biosciences Inc (NASDAQ:AKER) issued its quarterly earnings results on Thursday, November, 15th. The medical instruments supplier reported ($0.26) earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $0.56 million for the quarter. Akers Biosciences had a negative return on equity of 107.79% and a negative net margin of 346.69%. View Akers Biosciences' Earnings History.
When is Akers Biosciences' next earnings date?
Has Akers Biosciences been receiving favorable news coverage?
News articles about AKER stock have been trending positive this week, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Akers Biosciences earned a news impact score of 3.0 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 8.0 out of 10, meaning that recent media coverage is very likely to have an effect on the stock's share price in the next few days.
Who are some of Akers Biosciences' key competitors?
Who are Akers Biosciences' key executives?
Akers Biosciences' management team includes the folowing people:
- Mr. Gary M. Rauch, VP of Fin. & Treasurer (Age 62)
- Mr. Howard R. Yeaton Jr., CPA, CEO & Interim CFO (Age 63)
- Mr. Douglas Carrara, Sr. VP of Global Marketing & Commercial Operations
- Ms. Pamela E. Hibler, VP of Sales & Distribution
- Mr. Richard E. McKee, VP of Engineering
Who are Akers Biosciences' major shareholders?
Which major investors are buying Akers Biosciences stock?
How do I buy shares of Akers Biosciences?
Shares of AKER can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Akers Biosciences' stock price today?
One share of AKER stock can currently be purchased for approximately $1.16.
How big of a company is Akers Biosciences?
Akers Biosciences has a market capitalization of $14.47 million and generates $3.93 million in revenue each year. Akers Biosciences employs 32 workers across the globe.
What is Akers Biosciences' official website?
How can I contact Akers Biosciences?
Akers Biosciences' mailing address is 201 GROVE RD, THOROFARE NJ, 08086. The medical instruments supplier can be reached via phone at 856-848-8698 or via email at [email protected]
MarketBeat Community Rating for Akers Biosciences (NASDAQ AKER)
MarketBeat's community ratings are surveys of what our community members think about Akers Biosciences and other stocks. Vote "Outperform" if you believe AKER will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AKER will underperform the S&P 500 over the long term. You may vote once every thirty days.
